Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
ESGCT 2022: The New Normal for the Gene Therapy Community.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ESGCT 2022: The New Normal for the Gene Therapy Community.
Flotte TR. ESGCT 2022: The New Normal for the Gene Therapy Community. Hum Gene Ther. 2022 09; 33(17-18):841.
View in:
PubMed
subject areas
Community Health Services
Genetic Therapy
Humans
authors with profiles
Terence R Flotte MD